Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Koji Ohsumi"'
Autor:
Shiko Seki, Yuichi Nishihara, Kenichiro Omoto, Yoshiki Kawaguchi, Hidejirou Urakami, Jo Tokuyama, Yo Isobe, Koji Ohsumi, Takashi Ohishi, Atsushi Shimada
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 49:473-480
Autor:
Yasufumi Sato, Yukio Akiyama, Akira Okano, Katsuyoshi Hori, Toshihiro Hatanaka, Takashi Tsuruo, Kazuo Ohishi, Sachiko Saito, Takashi Tsuji, Yukio Nihei, Yasuyo Suga, Ryusuke Nakagawa, Yoshihiro Morinaga, Koji Ohsumi
Publikováno v:
Japanese Journal of Cancer Research : Gann
AC-7700, a novel combretastatin A-4 derivative, suppresses the growth of solid tumors by inhibiting tumor perfusion. We evaluated the antitumor activity of AC-7700 on solid tumors in two experimental models, an advanced tumor model (murine colon 26 (
Autor:
Koji Ohsumi, Yukio Nihei, Koichi Fujita, Takashi Tsuji, Toshihiro Hatanaka, Ryusuke Nakagawa, Yasuyo Suga, Yukio Akiyama, Yumiko Fukuda
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 8:3371-3374
A series of B-ring modified combretastatin analogues were synthesized and their inhibitory activity against microtubule assembly, cytotoxic activity against Colon 26 adenocarcinoma cancer cell line were evaluated. Among these, pyridone derivative (19
Autor:
Takashi Tsuji, Ryusuke Nakagawa, Yoshihiro Morinaga, Koji Ohsumi, Yukio Akiyama, Toshihiro Hatanaka, Yumiko Fukuda, Yukio Nihei, Koichi Fujita, Yasuyo Suga
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 8:3153-3158
A series of cis-restricted combretastatin analogues with 5-membered heterocycles were synthesized and their inhibitory activity against microtubule assembly and cytotoxic activity against the colon 26 adenocarcinoma cancer cell line were evaluated. S
Autor:
Koji Ohsumi, Yoshihiro Morinaga, Ohishi K, Yasuyo Suga, Takashi Tsuji, Ryusuke Nakagawa, Yukio Akiyama, Takashi Tsuruo
Publikováno v:
Cancer Chemotherapy and Pharmacology. 38:446-452
Purpose: We have previously shown that a series of N-alkylated 1,4-dihydropyridines potentiate the therapeutic efficacy of vincristine in vincristine-resistant P388 leukemia. The purpose of this study was to investigate the ability of one of the comp
Autor:
Takaaki Sekiyama, Yoshihiro Morinaga, Kazuo Ohishi, Takashi Tsuji, Koji Ohsumi, Takashi Tsuruo, Yukio Akiyama, Yasuyo Suga, Ryusuke Nakagawa
Publikováno v:
Chemical and Pharmaceutical Bulletin. 43:818-828
New N-alkylated 1,4-dihydropyridine derivatives were synthesized and their ability to overcome multidrug resistance was examined in vincristine-resistant P388 cells (P388/VCR cells). Compounds that possessed an arylalkyl substituent on the dihydropyr
Autor:
Takashi Tsuji, Yukio Akiyama, Yoshihiro Morinaga, Takashi Tsuruo, Koji Ohsumi, Takaaki Sekiyama, Ryusuke Nakagawa, Kazuo Ohishi, Yasuyo Suga
Publikováno v:
ChemInform. 26
New N-alkylated 1,4-dihydropyridine derivatives were synthesized and their ability to overcome multidrug resistance was examined in vincristine-resistant P388 cells (P388/VCR cells). Compounds that possessed an arylalkyl substituent on the dihydropyr
Autor:
Koji Ohsumi, Yasuyo Suga, Toshihiro Hatanaka, Takashi Tsuji, Yukio Akiyama, Yumiko Fukuda, Yukio Nihei, Kazuo Ohishi, Ryusuke Nakagawa, Yoshihiro Morinaga
Publikováno v:
ChemInform. 29
A series of combretastatin A-4 (CA-4) analogues were synthesized, and their cytotoxic effects against murine Colon 26 adenocarcinoma and inhibitory activity on tubulin polymerization were evaluated. Since CA-4 has limited aqueous solubility, the targ
Autor:
Yoshihiro Morinaga, Yumiko Fukuda, Ryusuke Nakagawa, Yukio Nihei, Takashi Tsuji, Koichi Fujita, Yukio Akiyama, Koji Ohsumi, Toshihiro Hatanake, Yasuyo Suga
Publikováno v:
ChemInform. 30
Autor:
Koji Ohsumi, Yumiko Fukuda, Ryusuke Nakagawa, Takashi Tsuji, Yukio Akiyama, Yukio Nihei, Koichi Fujita, Toshihiro Hatanaka, Yasuyo Suga
Publikováno v:
ChemInform. 30
A series of B-ring modified combretastatin analogues were synthesized and their inhibitory activity against microtubule assembly, cytotoxic activity against Colon 26 adenocarcinoma cancer cell line were evaluated. Among these, pyridone derivative (19